Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

129,622 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Role of p53 in transcriptional repression of SVCT2.
Kim EH, Koh DI, Ryu YS, Park SS, Hong SW, Moon JH, Shin JS, Kim MJ, Kim DY, Hong JK, Jeong HR, Yun H, Shin JY, Kim J, Park YS, Kim DM, Jin DH. Kim EH, et al. Among authors: kim dy, kim dm, kim j, kim mj. Mol Biol Rep. 2021 Feb;48(2):1651-1658. doi: 10.1007/s11033-021-06179-2. Epub 2021 Feb 12. Mol Biol Rep. 2021. PMID: 33580460
Targeting β-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutations.
Moon JH, Hong SW, Kim JE, Shin JS, Kim JS, Jung SA, Ha SH, Lee S, Kim J, Lee DH, Park YS, Kim DM, Park SS, Hong JK, Kim DY, Kim EH, Jung J, Kim MJ, Kim SM, Deming DA, Kim K, Kim TW, Jin DH. Moon JH, et al. Among authors: kim eh, kim tw, kim dy, kim js, kim dm, kim sm, kim je, kim j, kim mj, kim k. Br J Cancer. 2019 Apr;120(9):941-951. doi: 10.1038/s41416-019-0434-5. Epub 2019 Apr 4. Br J Cancer. 2019. PMID: 30944457 Free PMC article.
Inhibition of JAK1/2 can overcome EGFR-TKI resistance in human NSCLC.
Kim DM, Kim MJ, Moon JH, Lee EY, Hong JK, Lee S, Koh DI, Ryu YS, Kim SM, Jung SA, Shin JS, Kim J, Park YS, Hong SW, Lee SH, Jung J, Park SS, Kim DY, Kim EH, Jeong HR, Gong JH, Kim J, Chan Kim S, Yu HN, Ki SY, Kim TW, Jin DH. Kim DM, et al. Among authors: kim eh, kim tw, kim dy, kim sm, kim j, kim mj. Biochem Biophys Res Commun. 2020 Jun 18;527(1):305-310. doi: 10.1016/j.bbrc.2020.04.095. Epub 2020 May 11. Biochem Biophys Res Commun. 2020. PMID: 32446385
Mutation SVCT2 promotes cell proliferation, invasion and migration in colorectal cancer.
Park SS, Ryu YS, Koh DI, Hong SW, Moon JH, Shin JS, Kim MJ, Kim DY, Hong JK, Kim EH, Jeong HR, Park YS, Kim J, Kim DM, Yun H, Shin JY, Jin DH. Park SS, et al. Among authors: kim eh, kim dy, kim dm, kim j, kim mj. J Cancer. 2021 Jul 6;12(18):5385-5393. doi: 10.7150/jca.57463. eCollection 2021. J Cancer. 2021. PMID: 34405001 Free PMC article.
Mutant PIK3CA as a negative predictive biomarker for treatment with a highly selective PIM1 inhibitor in human colon cancer.
Park YS, Kim J, Ryu YS, Moon JH, Shin YJ, Kim JH, Hong SW, Jung SA, Lee S, Kim SM, Lee DH, Kim DY, Yun H, You JE, Yoon DI, Kim CH, Koh DI, Jin DH. Park YS, et al. Among authors: kim dy, kim ch, kim sm, kim j, kim jh. Cancer Biol Ther. 2023 Dec 31;24(1):2246208. doi: 10.1080/15384047.2023.2246208. Cancer Biol Ther. 2023. PMID: 37621144 Free PMC article.
Targeting isoforms of RON kinase (MST1R) drives antitumor efficacy.
Kim J, Koh DI, Lee M, Park YS, Hong SW, Shin JS, Lee MS, Kim MH, Lee JH, Jeong J, Bae S, Hong JK, Jeong HR, Ryu YS, Kim SM, Choi M, Kim H, Ryu H, Hur SC, Park J, Hur DY, Jin DH. Kim J, et al. Among authors: kim h, kim sm, kim mh. Cell Death Differ. 2023 Dec;30(12):2491-2507. doi: 10.1038/s41418-023-01235-9. Epub 2023 Nov 6. Cell Death Differ. 2023. PMID: 37926711
The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy.
Koh DI, Lee M, Park YS, Shin JS, Kim J, Ryu YS, Lee JH, Bae S, Lee MS, Hong JK, Jeong HR, Choi M, Hong SW, Kim DK, Lee HK, Kim B, Yoon YS, Jin DH. Koh DI, et al. Among authors: kim b, kim dk, kim j. Cancer Immunol Res. 2024 Apr 2;12(4):491-507. doi: 10.1158/2326-6066.CIR-23-0817. Cancer Immunol Res. 2024. PMID: 38289363
Totally laparoscopic versus laparoscopy-assisted distal gastrectomy: the KLASS-07, a randomized controlled trial.
Park SH, Lee CM, Hur H, Min JS, Ryu SW, Son YG, Chae HD, Jeong O, Jung MR, Choi CI, Song KY, Lee HH, Kim HG, Jee YS, Hwang SH, Lee MS, Kim KH, Seo SH, Jeong IH, Son MW, Kim CH, Yoo MW, Oh SJ, Kim JG, Hwang SH, Choi SI, Yang KS, Huang H, Park S. Park SH, et al. Among authors: kim jg. Int J Surg. 2024 May 6. doi: 10.1097/JS9.0000000000001543. Online ahead of print. Int J Surg. 2024. PMID: 38716987
129,622 results
You have reached the last available page of results. Please see the User Guide for more information.